{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06441162",
            "orgStudyIdInfo": {
                "id": "23-01357"
            },
            "organization": {
                "fullName": "NYU Langone Health",
                "class": "OTHER"
            },
            "briefTitle": "Efficacy Of Combined Nebulized Hypertonic Saline and Chest Percussion Therapy in Acute Viral Bronchiolitis",
            "officialTitle": "A Pilot, Non-randomized, Single-site Clinical Study Investigating the Efficacy of Combined Therapy of Nebulized 3% Hypertonic Saline and Chest Percussion Therapy in Pediatric Patients With Acute Viral Bronchiolitis.",
            "therapeuticArea": [
                "Other"
            ],
            "study": "efficacy-of-combined-nebulized-hypertonic-saline-and-chest-percussion-therapy-in-acute-viral-bronchiolitis"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-05-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-05-29",
            "studyFirstSubmitQcDate": "2024-05-29",
            "studyFirstPostDateStruct": {
                "date": "2024-06-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-16",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "NYU Langone Health",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This study will examine the efficacy of combined nebulized hypertonic saline with chest percussion therapy in patients age 0 to 24 months admitted to the general inpatient pediatrics unit with acute bronchiolitis. 3% nebulized hypertonic saline treatments combined with 3 minutes of chest percussion therapy will be administered every 6 hours of patients selected for the study."
        },
        "conditionsModule": {
            "conditions": [
                "Acute Bronchiolitis"
            ],
            "keywords": [
                "acute bronchiolitis",
                "nebulized hypertonic saline",
                "chest percussion therapy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 114,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Nebulized Hypertonic Saline + Chest Percussion Therapy",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with acute viral bronchiolitis will receive 3% nebulized hypertonic saline treatments combined with 3 minutes of chest percussion therapy. This will be administered every 6 hours.",
                    "interventionNames": [
                        "Drug: Nebulized 3% sodium chloride solution",
                        "Device: Chest percussion cups"
                    ]
                },
                {
                    "label": "Control Arm",
                    "type": "NO_INTERVENTION",
                    "description": "Participants in the control arm will be analyzed via retrospective chart review; these participants will not be consented nor enrolled in the trial."
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Nebulized 3% sodium chloride solution",
                    "description": "Standardized dose of nebulized 3% sodium chloride will be provided from 4 mL vial and administered be every 6 hours.",
                    "armGroupLabels": [
                        "Nebulized Hypertonic Saline + Chest Percussion Therapy"
                    ]
                },
                {
                    "type": "DEVICE",
                    "name": "Chest percussion cups",
                    "description": "The chest percussion cup is a small, flexible cup made of vinyl that is used to provide gentle chest wall vibrations to assist with airway clearance and is utilized in patients of all ages with sputum production, such as those with acute bronchiolitis. Administered every 6 hours while on supplemental oxygen therapy.",
                    "armGroupLabels": [
                        "Nebulized Hypertonic Saline + Chest Percussion Therapy"
                    ],
                    "otherNames": [
                        "MC-2247 Pediatric Manual Percussor Cup"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Length of Hospital Stay",
                    "description": "Measured in days from from time of admission to the general inpatient pediatrics unit until time of discharge from the general inpatient pediatrics unit.",
                    "timeFrame": "Up to time of discharge (Approximately 1-5 days on average)"
                },
                {
                    "measure": "Time on Supplemental Oxygen Support",
                    "description": "Measured in days from from time of admission to the general inpatient pediatrics unit until time of discharge from the general inpatient pediatrics unit.",
                    "timeFrame": "Up to time of discharge (Approximately 1-5 days on average)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Average Respiratory Rate",
                    "description": "Assessed every 4 hours and as needed in addition.",
                    "timeFrame": "Up to time of discharge (Approximately 1-5 days on average)"
                },
                {
                    "measure": "Average Heart Rate",
                    "description": "Assessed every 4 hours and as needed in addition.",
                    "timeFrame": "Up to time of discharge (Approximately 1-5 days on average)"
                },
                {
                    "measure": "Average Pulse Oximetry Reading",
                    "description": "Assessed every 4 hours and as needed in addition.",
                    "timeFrame": "Up to time of discharge (Approximately 1-5 days on average)"
                },
                {
                    "measure": "Number of Caregivers who Rate Child's Response as \"Improved\"",
                    "description": "Caregivers will be given a survey in which they will rate their child's overall response following the treatments as \"Improved,\" \"Unchanged,\" or \"Worsened.\"",
                    "timeFrame": "Time of discharge (Approximately 1-5 days on average)"
                },
                {
                    "measure": "Number of Physicians who Rate Child's Response as \"Improved\"",
                    "description": "Caregivers will be given a survey in which they will rate their child's overall response following the treatments as \"Improved,\" \"Unchanged,\" or \"Worsened.\"",
                    "timeFrame": "Time of discharge (Approximately 1-5 days on average)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nIn order to be eligible to participate in this study (experimental arm), an individual must meet all of the following criteria:\n\n* Age 0 to 24 months\n* Admitted to the general inpatient pediatrics unit\n* Has a diagnosis of acute bronchiolitis\n* Receiving supplemental oxygen support\n\nData collected for the control arm will be obtained via retrospective chart review for patients meeting the following inclusion criteria:\n\n* Age 0 to 24 months\n* Admitted to the general inpatient pediatrics unit\n* Has a diagnosis of acute bronchiolitis\n* Receiving supplemental oxygen support\n\nExclusion Criteria:\n\nAn individual who meets any of the following criteria will be excluded from participation in this study:\n\n* Admitted to the pediatric intensive care unit\n* Has an underlying pre-existing condition that may affect the respiratory system (includes bronchopulmonary dysplasia, reactive airways disease, asthma, restrictive lung diseases, other chronic lung diseases, etc.)\n* Has other comorbid conditions upon admission that may affect the respiratory system (includes pneumonia or other bacterial or fungal lung infections, acute exacerbation of reactive airways disease, acute exacerbation of asthma, pulmonary edema, pleural effusion, etc.)\n* Has an absolute contraindication to nebulized 3% hypertonic saline, for example, a history of an allergic or anaphylactic reaction\n* Is receiving other respiratory treatments such as bronchodilator treatments (i.e. albuterol or levalbuterol)\n* Is receiving other adjuvant therapy such as antibiotics, antivirals, glucocorticoids, corticosteroids, or diuretics\n\nA potential study subject in the control arm via retrospective chart review who meets any of the following criteria will be excluded from this study:\n\n* Admitted to the pediatric intensive care unit\n* Has an underlying pre-existing condition that may affect the respiratory system (includes bronchopulmonary dysplasia, reactive airways disease, asthma, restrictive lung diseases, other chronic lung diseases, etc.)\n* Has other comorbid conditions upon admission that may affect the respiratory system (includes pneumonia or other bacterial or fungal lung infections, acute exacerbation of reactive airways disease, acute exacerbation of asthma, pulmonary edema, pleural effusion, etc.)\n* Has an absolute contraindication to nebulized 3% hypertonic saline, for example, a history of an allergic or anaphylactic reaction\n* Is receiving other respiratory treatments such as bronchodilator treatments (i.e. albuterol or levalbuterol)\n* Is receiving other adjuvant therapy such as antibiotics, antivirals, glucocorticoids, corticosteroids, or diuretics",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "0 Months",
            "maximumAge": "24 Months",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Tuan Nguyen",
                    "role": "CONTACT",
                    "phone": "405-535-7093",
                    "email": "tuan.nguyen@nyulangone.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Tuan Nguyen",
                    "affiliation": "NYU Langone Health",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "NYU Langone Health",
                    "status": "RECRUITING",
                    "city": "Mineola",
                    "state": "New York",
                    "zip": "11501",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tuan Nguyen",
                            "role": "CONTACT",
                            "phone": "405-535-7093",
                            "email": "tuan.nguyen@nyulangone.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.74927,
                        "lon": -73.64068
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "The de-identified participant data from the final research dataset used in the published manuscript will be shared upon reasonable request beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the investigator who proposes to use the data executes a data use agreement with NYU Langone Health. Requests may be directed to: Tuan Nguyen tuan.nguyen@nyulangone.org 405-535-7093 The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF",
                "CSR"
            ],
            "timeFrame": "Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.",
            "accessCriteria": "The investigator who proposed to use the data will be granted access upon reasonable request. Requests should be directed to tuan.nguyen@nyulangone.org. To gain access, data requestors will need to sign a data access agreement."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001988",
                    "term": "Bronchiolitis"
                },
                {
                    "id": "D000001990",
                    "term": "Bronchiolitis, Viral"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001991",
                    "term": "Bronchitis"
                },
                {
                    "id": "D000012141",
                    "term": "Respiratory Tract Infections"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000001982",
                    "term": "Bronchial Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000008173",
                    "term": "Lung Diseases, Obstructive"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5264",
                    "name": "Bronchiolitis",
                    "asFound": "Bronchiolitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5266",
                    "name": "Bronchiolitis, Viral",
                    "asFound": "Viral Bronchiolitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5267",
                    "name": "Bronchitis",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14978",
                    "name": "Respiratory Tract Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M5258",
                    "name": "Bronchial Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11170",
                    "name": "Lung Diseases, Obstructive",
                    "relevance": "LOW"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}